sec filing
AMEX · PLX
Protalix BioTherapeutics, Inc. Common Stock
Healthcare · Biotechnology
$2.56
Up+$0.05 (+1.95%)
Updated Nov 4, 2026, 1:11 AM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 146.37M
- P/E ratio
- 26.75
- Dividend yield
- 0.00%
- 52-week range
- $1.88 – $2.98
- Volume
- 726.27K
- Avg. volume
- 789.76K
Price performance · PLX
PLX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 2, 2026
PLX closed at $2.56 after 20 trading sessions, down 6.23% for the selected period.
- Last close
- $2.56
- Period change
- -6.23%
- Period low
- $2.48
- Period high
- $2.78
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 2, 2026 | $2.60 | $2.62 | $2.54 | $2.56 | 726.27K |
| Oct 30, 2026 | $2.60 | $2.63 | $2.565 | $2.59 | 249.29K |
| Oct 29, 2026 | $2.59 | $2.68 | $2.59 | $2.61 | 274.76K |
| Oct 28, 2026 | $2.51 | $2.62 | $2.47 | $2.59 | 596.66K |
| Oct 27, 2026 | $2.48 | $2.545 | $2.46 | $2.53 | 448.3K |
| Oct 26, 2026 | $2.55 | $2.55 | $2.46 | $2.48 | 416.27K |
| Oct 23, 2026 | $2.54 | $2.56 | $2.495 | $2.55 | 383.91K |
| Oct 22, 2026 | $2.53 | $2.60 | $2.53 | $2.57 | 457.11K |
| Oct 21, 2026 | $2.60 | $2.635 | $2.53 | $2.57 | 561.52K |
| Oct 20, 2026 | $2.58 | $2.65 | $2.5775 | $2.64 | 702.71K |
| Oct 19, 2026 | $2.63 | $2.66 | $2.535 | $2.56 | 914.83K |
| Oct 16, 2026 | $2.70 | $2.70 | $2.61 | $2.62 | 1.19M |
| Oct 15, 2026 | $2.63 | $2.75 | $2.62 | $2.70 | 1.14M |
| Oct 14, 2026 | $2.73 | $2.775 | $2.61 | $2.61 | 1.53M |
| Oct 13, 2026 | $2.80 | $2.80 | $2.735 | $2.75 | 967.79K |
| Oct 12, 2026 | $2.75 | $2.80 | $2.71 | $2.78 | 717.14K |
| Oct 9, 2026 | $2.70 | $2.785 | $2.69 | $2.78 | 1.2M |
| Oct 8, 2026 | $2.68 | $2.71 | $2.61 | $2.70 | 972.85K |
| Oct 7, 2026 | $2.70 | $2.765 | $2.68 | $2.71 | 794.73K |
| Oct 6, 2026 | $2.74 | $2.76 | $2.65 | $2.73 | 934.74K |
Latest PLX news
The latest Smart Investors Daily articles mentioning PLX.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…